Julia Lainster

The systematic transition from traditional observational medicine to the contemporary era of rigorous clinical validation has revolutionized how society identifies, develops, and distributes therapeutic interventions intended to alleviate human suffering and prolong life across diverse populations

The biopharmaceutical industry is witnessing a fundamental departure from passive pharmaceutical agents to complex, programmable biological machines that actively navigate the human body. This shift marks the rise of multifunctional Chimeric Antigen Receptor (CAR) T-cell therapy, a modality that

Ivan Kairatov stands at the forefront of biopharmaceutical innovation, possessing a wealth of experience in research, development, and the integration of advanced technologies into clinical practice. His deep understanding of the technical and cognitive demands placed on medical professionals

The biological complexity of the human retina offers a uniquely transparent gateway into the body's cardiovascular and neurological systems through advanced imaging technology. This anatomical window allows clinicians and researchers to observe microvascular and neural health in real-time without

The persistent evolution of the opioid epidemic from prescription pills to the devastating prevalence of synthetic fentanyl has left public health officials searching for faster ways to monitor and respond to overdose spikes. Traditional reporting systems, while robust, often suffer from

Every year on April 25, the global scientific community pauses to recognize DNA Day, a date that marks the monumental publication of the double-helix structure in 1953 and the triumphant completion of the Human Genome Project in 2003. For the researchers at The Institute of Cancer Research (ICR),

Missed by the very blood tests meant to reveal them, too many testicular cancers slip through diagnostic nets just when speed matters most for adolescents and young adults facing life-shaping treatment choices. That gap is precisely what a new high-dimensional immune profiling approach set out to

For patients living with a chronic Achilles rupture that has resisted months of therapy and bracing, every step can feel like a wager against pain, weakness, instability, and the fear that a compromised tendon will fail again during even the simplest tasks. Traditional reconstruction can fix the

Colorectal cancer remains a top killer, yet traditional screening pathways leave many behind. Clinic-based outreach depends on staffed phone banks, open appointment slots, and patients’ ability to take time off, travel, and navigate insurance rules. In safety-net settings, those frictions stack.

Ivan Kairatov brings hands‑on R&D experience in neuromuscular drug development and a clear view of how dosing, delivery, and clinic operations intersect in real life. With the MHRA authorizing a higher‑dose nusinersen regimen, he explains how two 50mg loading doses 14 days apart and 28mg